tor 3271 patienter, der fik Trudexa, og 1809 patienter, der fik enten placebo eller aktiv kontrol i den kontrollerede behandlingsperiode.
The data in Table 1 is based on the controlled Studies (I− IX, CLASSIC I, GAIN AND CHARM) (described in section 5.1) involving 3271 patients receiving Trudexa and 1809 patients receiving placebo or active comparator during the controlled period.